Inventor · disambiguated record
Robert Florkiewicz
Also filed as: FLORKIEWICZ ROBERT · FLORKIEWICZ ROBERT Z
27 granted patents·4 pending applications·271 citations·filing 1991–2021
97Inventor score
Files withAVANIR PHARMACEUTICALS14TAPIMMUNE INC5SCRIPPS RESEARCH INST4CIBLEX CORP3MARKER THERAPEUTICS INC2
Top patents by PatentIndex Score
31 records- 0195US7084141B2Inhibitors of macrophase migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2005·Granted Aug 1, 2006·27 cites·44 claims
- 0290US7514225B2Method for screening an agent that modulates activity of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2005·Granted Apr 7, 2009·8 cites·11 claims
- 0389US7105519B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2002·Granted Sep 12, 2006·17 cites·107 claims
- 0487US7129236B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Oct 31, 2006·5 cites·42 claims
- 0586US5891855AInhibitors of leaderless protein exportSCRIPPS RESEARCH INST·Filed 1996·Granted Apr 6, 1999·47 cites·17 claims
- 0684US7732146B2Method for screening an agent that modulates activity of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2005·Granted Jun 8, 2010·3 cites·9 claims
- 0784US7192961B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Mar 20, 2007·3 cites·27 claims
- 0882US7432374B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2007·Granted Oct 7, 2008·2 cites·7 claims
- 0981US7435737B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Oct 14, 2008·2 cites·11 claims
- 1081US6071885ATreatment of FGF-mediated conditions by administration of a cardiac glycoside or aglycone derivative thereofSCRIPPS RESEARCH INST·Filed 1998·Granted Jun 6, 2000·33 cites·9 claims
- 1178US7238809B2Process for the preparation of inhibitors of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2006·Granted Jul 3, 2007·1 cites·24 claims
- 1278US7235565B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Jun 26, 2007·1 cites·52 claims
- 1378US7230106B2Process for the preparation of inhibitors of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2006·Granted Jun 12, 2007·1 cites·19 claims
- 1478US7202248B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Apr 10, 2007·1 cites·62 claims
- 1578US7157469B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Jan 2, 2007·1 cites·42 claims
- 1678US5332804AHigh molecular weight human angiogenic basic fibroblast growth factorsSYNERGEN INC·Filed 1991·Granted Jul 26, 1994·36 cites·5 claims
- 1777US10030252B2Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereofTAPIMMUNE INC·Filed 2016·Granted Jul 24, 2018·1 cites·21 claims
- 1877US2022033844A1Chimeric nucleic acid molecules with non-aug translation initiation sequences and uses thereofMARKER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1977US2022056473A1Chimeric nucleic acid molecules with non-aug translation initiation sequences and uses thereofMARKER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2076US7192955B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Mar 20, 2007·1 cites·52 claims
- 2165US2018163226A1Chimeric nucleic acid molecules with non-aug translation initiation sequences and uses thereofTAPIMMUNE INC·Filed 2018·Application pending·0 cites
- 2265US2018230487A1Chimeric nucleic acid molecules with non-aug translation initiation sequences and uses thereofTAPIMMUNE INC·Filed 2018·Application pending·0 cites
- 2363US9988643B2Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereofTAPIMMUNE INC·Filed 2016·Granted Jun 5, 2018·0 cites·27 claims
- 2462US6281197B1Cardiac glycosides and their aglycone derivatives treat complications of diabetesSCRIPPS RESEARCH INST·Filed 1999·Granted Aug 28, 2001·15 cites·7 claims
- 2561US6083706AInhibitors of leaderless protein exportCIBLEX CORP·Filed 1998·Granted Jul 4, 2000·18 cites·6 claims
- 2660US9364523B2Chimeric nucleic acid molecule with non-AUG translation initiation sequencesTAPIMMUNE INC·Filed 2015·Granted Jun 14, 2016·0 cites·30 claims
- 2759US9655956B2Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereofTAPLMMUNE INC·Filed 2016·Granted May 23, 2017·0 cites·53 claims
- 2859US6028058AMethods and compositions for regulating nuclear trafficking of proteinsCIBLEX CORP·Filed 1997·Granted Feb 22, 2000·15 cites·4 claims
- 2958US6107283ACardiac glycosides inhibit proliferation of cells bearing FGF receptorsSCRIPPS RESEARCH INST·Filed 1999·Granted Aug 22, 2000·12 cites·7 claims
- 3051US5188943AMethod of producing high molecular weight human fibroblast growth factorsSYNERGEN INC·Filed 1991·Granted Feb 23, 1993·10 cites·1 claims
- 3141US6306613B1Modulators of leaderless protein export and methods for identifying and using the sameCIBLEX CORP·Filed 1999·Granted Oct 23, 2001·11 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Robert Florkiewicz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →